|1.||Patterson, Bruce W: 8 articles (08/2013 - 06/2002)|
|2.||Mittendorfer, Bettina: 7 articles (08/2013 - 03/2003)|
|3.||Klein, Samuel: 7 articles (06/2012 - 03/2003)|
|4.||Nielsen, Søren: 3 articles (05/2013 - 03/2007)|
|5.||Christiansen, Jens S: 3 articles (05/2013 - 03/2007)|
|6.||Gormsen, Lars C: 3 articles (05/2013 - 03/2007)|
|7.||Rensen, Patrick C N: 3 articles (12/2011 - 07/2005)|
|8.||Havekes, Louis M: 3 articles (12/2011 - 07/2005)|
|9.||Hodson, Leanne: 2 articles (01/2015 - 05/2011)|
|10.||Parks, Elizabeth J: 2 articles (01/2015 - 06/2014)|
02/01/1989 - "Fasting plasma total and very-low-density lipoprotein (VLDL) triglyceride (TG) concentrations increased by 30% (P less than .001) after 1 wk on the 60% carbohydrate diet, and the magnitude of carbohydrate-induced hypertriglyceridemia persisted unchanged throughout the 6-wk study period. "
04/01/1985 - "In this report, kinetic studies of plasma very low-density lipoprotein-triglyceride (VLDL-TG) were examined in five brothers (three affected and two unaffected) from a family with primary hypertriglyceridemia. "
06/01/2014 - "Data have amassed on the contributions of each of these sources to liver-triglyceride accrual, VLDL-triglyceride synthesis, and hypertriglyceridemia. "
12/01/2013 - "Prandial hypertriglyceridemia in metabolic syndrome is due to an overproduction of both chylomicron and VLDL triacylglycerol."
02/01/2000 - "Analysis of triglyceride metabolism in these animals demonstrated a several-fold increase in hepatic very-low density lipoprotein triglyceride secretion, the most prevalent mechanism responsible for hypertriglyceridemia in humans. "
|2.||Type 2 Diabetes Mellitus (MODY)
03/01/1983 - "Very-low-density lipoprotein triglyceride metabolism in non-insulin-dependent diabetes mellitus. "
09/01/1991 - "In NIDDM, increased VLDL triglyceride and reduced HDL cholesterol concentrations are common and are only partially related to glycemic control. "
09/01/1990 - "These observations are concordant with the hypothesis that NIDDM patients overproduce VLDL triglyceride but not apoB. "
11/01/1988 - "Thus, in NIDDM patients, dietary supplementation with omega-3 fatty acids induces a reduction in total plasma and VLDL triglyceride levels.(ABSTRACT TRUNCATED AT 250 WORDS)"
11/01/1988 - "Non-insulin-dependent diabetes mellitus (NIDDM) is associated with elevated very-low-density lipoprotein (VLDL) triglyceride concentrations and abnormalities of low-density lipoprotein (LDL) composition. "
11/01/2015 - "We hypothesized that increased very-low-density lipoprotein-triglyceride (VLDL-TG) secretion by the liver in a rat model for dyslipidemia, that is, the obese Zucker (fa/fa) rat, is due to relative hyperactivity of sympathetic, and/or hypoactivity of parasympathetic hepatic innervation. "
12/01/2009 - "In addition, increased free fatty acid delivery to the liver can stimulate hepatic very low-density lipoprotein triglyceride production, leading to dyslipidemia."
03/01/2015 - "Elevated very low-density lipoprotein (VLDL)-triglyceride (TG) secretion from the liver contributes to an atherogenic dyslipidemia that is associated with obesity, diabetes and the metabolic syndrome. "
05/01/2011 - "In fat-fed Ldlr(-/-) mice, nobiletin attenuated dyslipidemia through a reduction in VLDL-triglyceride (TG) secretion. "
12/01/1999 - "These results show that the molecular mechanisms by which cyclosporin causes dyslipoproteinemia may, in part, be mediated by selective activation of SREBP-2, leading to enhanced expression of lipid metabolism genes and hepatic secretion of VLDL triglyceride."
04/01/2003 - "VLDL-triglyceride kinetics during hyperglycemia-hyperinsulinemia: effects of sex and obesity."
11/01/1996 - "Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man."
04/01/1987 - "In NIDDM plasma total and VLDL triglyceride levels are elevated, and HDL-cholesterol level is decreased, and this pattern of dyslipoproteinemia does not always respond to improved control of hyperglycemia. "
06/01/1996 - "The effects of dietary fructose alone or in combination with a new oral agent, pioglitazone, on VLDL-triglyceride (TG) turnover were studied in genetically obese Wistar fatty rats characterized by hyperinsulinemia (7,488 +/- 954 pmol/l), hyperglycemia, (22.5 +/- 1.4 mmol/l), and hypertriglyceridemia (4.39 +/- 0.54 mmol/l). "
04/01/1990 - "The mechanism for the development of hypertriglyceridemia during gram-negative sepsis was studied by examining liver production and clearance of very-low-density lipoprotein (VLDL) triglyceride (TG). "
11/01/1993 - "The increased hepatic production of apo B represents an increased number of very low density lipoprotein (VLDL) particles and contributes to the elevated VLDL triglyceride levels seen in sepsis. "
|5.||Nonesterified Fatty Acids (NEFA)
|9.||Apolipoproteins B (ApoB)
|10.||Plasminogen Activator Inhibitor 1
|2.||Transplantation (Transplant Recipients)